BLA
PFE icon

Balter Liquid Alternatives’s Pfizer PFE Stock Holding History

Balter Liquid Alternatives’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,502
Closed -$244K – 152
2017
Q1 		$244K Sell
7,502
-8,034
-52% -$253K 0.35% 71
2016
Q4 		$479K Sell
15,536
-4,903
-24% -$150K 1.09% 28
2016
Q3 		$657K Hold
20,439
– – 1.65% 20
2016
Q2 		$683K Buy
20,439
+1,289
+7% +$41.1K 1.6% 19
2016
Q1 		$539K Buy
+19,150
New +$547K 1.24% 25

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Balter Liquid Alternatives's PFE Position: Q2 2017 in Review

Balter Liquid Alternatives sold out of Pfizer (PFE) in Q2 2017, closing a stake of 7,502 shares — an estimated $244K sold.

Balter Liquid Alternatives first reported a position in PFE in Q1 2016 and held it in 5 quarters. The position peaked at $683K in Q2 2016. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • Balter Liquid Alternatives reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
  • Balter Liquid Alternatives sold 7,502 Pfizer shares in Q2 2017, an estimated $244K.
  • Balter Liquid Alternatives first reported a position in Pfizer in Q1 2016 and held it in 5 quarters.
  • Balter Liquid Alternatives's Pfizer position peaked at $683K in Q2 2016.
  • 2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Balter Liquid Alternatives's 13F filing for Q2 2017, filed 7 Aug 2017.